Circulating tumour DNA (CtDNA) as a liquid biopsy for melanoma

Calapre, Leslie, Warburton, Lydia, Millward, Michael, Ziman, Mel, Gray, Elin S.·2017·Cancer Letters
DOI 10.1016/j.canlet.2017.06.030

Cited by (118)

Items 101–118 of 118

  1. Biomarkers for Melanoma
    Dirk Schadendorf, Keith T. Flaherty, Lyn M. Duncan, Mohammed Kashani–Sabet, Selma Ugurel · 2020 · Springer eBooks
  2. Evaluating Tumor Dynamics Using Circulating Tumor DNA in the Rare Cancer Anorectal Malignant Melanoma: A Report of Two Cases
    Goro Takahashi, Takeshi Yamada, Keisuke Uehara, Seiichi Shinji, Akihisa Matsuda, Yasuyuki Yokoyama, Takuma Iwai, Toshimitsu Miyasaka, Shintaro Kanaka, Yuta Kikuchi et al. · 2025 · Surgical Case Reports
  3. Advances in detection of nucleic acid tumor biomarkers via electrochemical biosensors
    YuXun LU, Hui Jing Zhao, CanPeng LI · 2019 · Scientia Sinica Vitae
  4. Liquid Biopsies
    Maria Palmieri, Elisa Frullanti, Renieri Alessandra · 2020 · Springer eBooks
  5. Emerging Concepts in Liquid Biopsy
    Siddhartha Sen, Michael Datto, Sarah Rapisardo · 2018 · Advances in Molecular Pathology
  6. Immune Checkpoint Inhibitors: A Step forward in Cancer Management
    Maria Rosaria Carratù, Maria Assunta Potenza, Carmela Nacci, Domenico De Rasmo, Anna Signorile · 2019 · Madridge Journal of Oncogenesis
  7. Association Between Tumor Budding Grade and T Stage in Predicting Recurrence in High-risk Stage Ii Colorectal Cancer
    Hiroyuki Kodama, Toshifumi Yamaguchi, Yasunobu Ishizuka, Masahiko Aoki, Takahiro Miyamoto, Tetsuji Terazawa, Fukutaro Shimamoto, Masahiro Goto, Hiroki Hamamoto, Wataru Osumi et al. · 2021 · Research Square
  8. Liquid biopsy in NSCLC: a new challenge in radiation therapy
    Annarita Perillo, M.V. Agbaje Olufemi, Jacopo De Robbio, Rossella Margherita Mancuso, Anna Roscigno, M. Tirozzi, Ida Rosalia Scognamiglio · 2021 · Exploration of Targeted Anti-tumor Therapy
  9. NRAS Q61R-mutant mucosal melanoma with cardiac metastasis - a diagnostic challenge
    Danai Dima · 2020 · MOJ Clinical & Medical Case Reports
  10. Assessment of the clinical validity of ctDNA Analysis for melanoma management
    Anda-Gabriela Marsavela · 2021 · Australasian Journal of Paramedicine
  11. Translational research of combined anticancer therapies targeting the MAPK pathway
    Sanne C.F.A. Huijberts · 2021
  12. Biomarkers for Melanoma
    Dirk Schadendorf, Keith T. Flaherty, Lyn M. Duncan, Mohammed Kashani–Sabet, Selma Ugurel · 2019 · Springer eBooks
  13. CTLA-4 Inhibitors for the Treatment of Lung Cancer
    Shvetank Bhatt, Shreya Sharma, Shubham Patil, Rohini Pujari · 2024 · Springer eBooks
  14. The ctDNA revolution: Insights on cancer care: A narrative review
    Krutika Mahendra Gohil, Joshua P. Reddy, Saniya Kifayetulla Mulla, Rishika Singh, Reena Shah, Sagar Mahendra Gohil · 2024 · Bioinformation
  15. Contribution de différents biomarqueurs à l’élaboration d’une stratégie thérapeutique dans le mélanome BRAF muté
    Laëtitia Vercellino · 2017 · theses.fr (ABES)
  16. Future Horizons: Emerging Technologies and Trends in Cancer Research
    Dinesh Kumar, Savita Deokar, Rajib Singh, Shilpa S. Borkar, Debarshi Kar Mahapatra, Puja Gulati, Prashant D. Ghode, Shweta P. Ghode · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  17. Recent advancements in breast cancer therapy
    Krishna Sanka, Mahendra Kumar Prajapati, Harsha Jain, Satish V. Rojekar, Ramesh Jadhav, Saurabh Maru · 2026 · Elsevier eBooks
  18. Prognostic value of circulating tumor cells in stage III and IV melanoma: a systematic review and meta-analysis
    Jennifer Hechao Chen, Hyunsoo Hwang, Bamboo Dong, Vanessa Nicole Sarli, Joshua R. Upshaw, Salyna Meas, Anthony Lucci · 2026 · Melanoma Research